Such synergistic approaches, combining complementary methodologies, are crucial for a holistic understanding of redox dysregulation, facilitating the identification of reliable biomarkers, and guiding the development of more effective, targeted antioxidant therapies to improve clinical outcomes in CF
It promotes extracellular matrix remodeling, reduces oxidative stress markers, and has demonstrated the ability to inhibit fibrosis in organs like the liver and lungs
The DHT blockers address hormonal factors while the copper peptide addresses cellular factors
Elevated BCAA levels have been linked to impaired insulin signaling and reduced metabolic flexibility
Sinclair has received several additional awards including a Helen Hay Whitney Postdoctoral Award, and a Special Fellowship from the Leukemia Society, a Ludwig Scholarship, a Harvard-Armenise Fellowship, an American Association for Aging Research Fellowship, and is currently a New Scholar of the Ellison Medical Foundation